Journal
NEUROSURGERY CLINICS OF NORTH AMERICA
Volume 33, Issue 3, Pages 305-309Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.nec.2022.02.007
Keywords
Central nervous system; Intrathecal therapy; Morphine; Neurosurgery; Pain; Ziconotide
Categories
Ask authors/readers for more resources
Intrathecal delivery of pain management medications is a significant advancement in treating chronic pain, demonstrating higher efficiency and fewer side effects compared to oral medications. However, more randomized controlled trials are needed to strengthen the evidence for intrathecal therapy. It is often considered a last resort for patients with nonmalignant pain. Updated expert guidelines on intrathecal treatment consensus are required.
Intrathecal delivery of pain management medications marks a significant step in the treatment of chronic pain. When compared with oral delivery of analgesics, intrathecal therapy has shown to be efficient with few side effects.19 However, further research, specifically in the form of randomized control trials, is needed to strengthen the evidence for intrathecal therapy. Currently, intrathecal therapy in the setting of nonmalignant pain is often the last resort for these patients. Updated guidelines by experts in the field on the consensus of intrathecal treatment are needed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available